vs

Side-by-side financial comparison of Alpha Metallurgical Resources, Inc. (AMR) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

Alpha Metallurgical Resources, Inc. is the larger business by last-quarter revenue ($519.1M vs $270.8M, roughly 1.9× HUTCHMED (China) Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -3.3%, a 4.0% gap on every dollar of revenue. On growth, Alpha Metallurgical Resources, Inc. posted the faster year-over-year revenue change (-15.7% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-10.0M).

Alpha Metallurgical Resources, formerly Contura Energy, is a leading coal supplier with underground and surface coal mining complexes across Northern and Central Appalachia. Contura owns large coal basins in Pennsylvania, Virginia and West Virginia which supply both metallurgical coal to produce steel and thermal coal to generate power.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

AMR vs HCM — Head-to-Head

Bigger by revenue
AMR
AMR
1.9× larger
AMR
$519.1M
$270.8M
HCM
Growing faster (revenue YoY)
AMR
AMR
+0.9% gap
AMR
-15.7%
-16.5%
HCM
Higher net margin
HCM
HCM
4.0% more per $
HCM
0.7%
-3.3%
AMR
More free cash flow
HCM
HCM
$13.3M more FCF
HCM
$3.4M
$-10.0M
AMR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMR
AMR
HCM
HCM
Revenue
$519.1M
$270.8M
Net Profit
$-17.3M
$2.0M
Gross Margin
37.7%
Operating Margin
-4.1%
-13.2%
Net Margin
-3.3%
0.7%
Revenue YoY
-15.7%
-16.5%
Net Profit YoY
-711.2%
-83.6%
EPS (diluted)
$-1.35
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMR
AMR
HCM
HCM
Q4 25
$519.1M
$270.8M
Q3 25
$525.2M
Q2 25
$548.7M
$277.7M
Q1 25
$529.7M
$324.5M
Q4 24
$615.4M
Q3 24
$669.8M
Q2 24
$800.1M
$305.7M
Q1 24
$861.3M
Net Profit
AMR
AMR
HCM
HCM
Q4 25
$-17.3M
$2.0M
Q3 25
$-5.5M
Q2 25
$-5.0M
$455.0M
Q1 25
$-33.9M
$11.9M
Q4 24
$-2.1M
Q3 24
$3.8M
Q2 24
$58.9M
$25.8M
Q1 24
$127.0M
Gross Margin
AMR
AMR
HCM
HCM
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
AMR
AMR
HCM
HCM
Q4 25
-4.1%
-13.2%
Q3 25
-0.5%
Q2 25
0.5%
-1.3%
Q1 25
-7.6%
-5.0%
Q4 24
1.6%
Q3 24
0.8%
Q2 24
8.8%
-9.0%
Q1 24
16.5%
Net Margin
AMR
AMR
HCM
HCM
Q4 25
-3.3%
0.7%
Q3 25
-1.1%
Q2 25
-0.9%
163.8%
Q1 25
-6.4%
3.7%
Q4 24
-0.3%
Q3 24
0.6%
Q2 24
7.4%
8.4%
Q1 24
14.7%
EPS (diluted)
AMR
AMR
HCM
HCM
Q4 25
$-1.35
$0.00
Q3 25
$-0.42
Q2 25
$-0.38
$0.52
Q1 25
$-2.60
$0.01
Q4 24
$-0.09
Q3 24
$0.29
Q2 24
$4.49
$0.03
Q1 24
$9.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMR
AMR
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$415.6M
$1.4B
Total DebtLower is stronger
$9.8M
$93.2M
Stockholders' EquityBook value
$1.5B
$1.2B
Total Assets
$2.3B
$1.8B
Debt / EquityLower = less leverage
0.01×
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMR
AMR
HCM
HCM
Q4 25
$415.6M
$1.4B
Q3 25
$457.9M
Q2 25
$449.0M
$1.4B
Q1 25
$448.0M
$836.1M
Q4 24
$481.6M
Q3 24
$484.6M
Q2 24
$336.1M
$802.5M
Q1 24
$269.4M
Total Debt
AMR
AMR
HCM
HCM
Q4 25
$9.8M
$93.2M
Q3 25
$2.9M
Q2 25
$3.1M
$93.4M
Q1 25
$2.4M
$82.8M
Q4 24
$2.9M
Q3 24
$3.6M
Q2 24
$5.3M
$82.1M
Q1 24
$6.0M
Stockholders' Equity
AMR
AMR
HCM
HCM
Q4 25
$1.5B
$1.2B
Q3 25
$1.6B
Q2 25
$1.6B
$1.2B
Q1 25
$1.6B
$759.9M
Q4 24
$1.6B
Q3 24
$1.7B
Q2 24
$1.6B
$740.1M
Q1 24
$1.6B
Total Assets
AMR
AMR
HCM
HCM
Q4 25
$2.3B
$1.8B
Q3 25
$2.3B
Q2 25
$2.4B
$1.8B
Q1 25
$2.4B
$1.3B
Q4 24
$2.4B
Q3 24
$2.5B
Q2 24
$2.5B
$1.3B
Q1 24
$2.5B
Debt / Equity
AMR
AMR
HCM
HCM
Q4 25
0.01×
0.08×
Q3 25
0.00×
Q2 25
0.00×
0.08×
Q1 25
0.00×
0.11×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
0.11×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMR
AMR
HCM
HCM
Operating Cash FlowLast quarter
$19.0M
$8.2M
Free Cash FlowOCF − Capex
$-10.0M
$3.4M
FCF MarginFCF / Revenue
-1.9%
1.2%
Capex IntensityCapex / Revenue
5.6%
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$17.8M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMR
AMR
HCM
HCM
Q4 25
$19.0M
$8.2M
Q3 25
$50.5M
Q2 25
$53.2M
$-72.9M
Q1 25
$22.2M
$40.3M
Q4 24
$56.3M
Q3 24
$189.5M
Q2 24
$138.1M
$-39.8M
Q1 24
$196.1M
Free Cash Flow
AMR
AMR
HCM
HCM
Q4 25
$-10.0M
$3.4M
Q3 25
$25.4M
Q2 25
$18.6M
$-82.2M
Q1 25
$-16.3M
$32.5M
Q4 24
$13.6M
Q3 24
$158.0M
Q2 24
$77.0M
$-49.9M
Q1 24
$132.5M
FCF Margin
AMR
AMR
HCM
HCM
Q4 25
-1.9%
1.2%
Q3 25
4.8%
Q2 25
3.4%
-29.6%
Q1 25
-3.1%
10.0%
Q4 24
2.2%
Q3 24
23.6%
Q2 24
9.6%
-16.3%
Q1 24
15.4%
Capex Intensity
AMR
AMR
HCM
HCM
Q4 25
5.6%
1.8%
Q3 25
4.8%
Q2 25
6.3%
3.3%
Q1 25
7.3%
2.4%
Q4 24
6.9%
Q3 24
4.7%
Q2 24
7.6%
3.3%
Q1 24
7.4%
Cash Conversion
AMR
AMR
HCM
HCM
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
49.81×
Q2 24
2.34×
-1.54×
Q1 24
1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons